Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol (Q80058660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Schwarz UI

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hanso H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Oertel R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Miehlke S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kuhlisch E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Glaeser H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hitzl M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Dresser GK

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kim RB

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kirch W

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

28 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

669-678

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17392718%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100191

28 December 2019

exact match

0 references

cites work

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Hypericum for depression. An update of the clinical evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's wort-associated drug interactions: short-term inhibition and long-term induction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Herb-drug interactions: review and assessment of report reliability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Interactions between herbal medicines and prescribed drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Pharmacokinetic interactions between herbal remedies and medicinal drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Drug interaction of St John's wort with cyclosporin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Safety of St John's wort (Hypericum perforatum)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Indinavir concentrations and St John's wort.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Drug interaction between St John's wort and nevirapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Effects of St. John's wort on irinotecan metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Potential metabolic interaction between St. John's wort and theophylline

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's wort interaction with digoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Second thoughts about safety of St John's wort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's Wort supplements endanger the success of organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's wort, a herbal antidepressant, activates the steroid X receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Importance of P-glycoprotein for drug disposition in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St John's Wort: effect on CYP3A4 activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Elucidation of the structure of talinolol metabolites in man. Determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Disposition and bioavailability of the beta 1-adrenoceptor antagonist talinolol in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Drug-activated nuclear receptors CAR and PXR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The effect of rifampin administration on the disposition of fexofenadine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

A family of drug transporters: the multidrug resistance-associated proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Regulation of drug and bile salt transporters in liver and intestine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Grapefruit juice ingestion significantly reduces talinolol bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100191

7 January 2021